Evidence map›Paper›PMID 36718633›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2023

Oxidative and Fibrinolytic Mechanisms: Two Important Processes to Consider in Platelet Storage

Jesus Javier Garcia-Bañuelos, Marina Galicia-Moreno, Hugo Christian Monroy-Ramirez, Jose Navarro-Partida, Blanca Estela Bastidas-Ramirez, Arturo Santos, Juan Armendariz-Borunda

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jesus Javier Garcia-BañuelosInstituto de Biología Molecular en Medicina y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, MexicoORCID 0000-0003-3430-9391
Marina Galicia-MorenoInstituto de Biología Molecular en Medicina y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, MexicoORCID 0000-0002-7435-1861
Hugo Christian Monroy-RamirezInstituto de Biología Molecular en Medicina y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, MexicoORCID 0000-0001-8891-5317
Jose Navarro-PartidaTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Jalisco, MexicoORCID 0000-0002-3895-821X
Blanca Estela Bastidas-RamirezInstituto en Investigación en Enfermedades Crónico Degenerativas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, MexicoORCID 0000-0002-2094-4178
Arturo SantosTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Jalisco, MexicoORCID 0000-0003-4640-7263
Juan Armendariz-BorundaInstituto de Biología Molecular en Medicina y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, MexicoORCID 0000-0002-7101-9943
Universidad de Guadalajara · MXTecnológico de Monterrey · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Platelet-rich plasma (PRP) is used in multiple coagulation disorders. Its therapeutic effectiveness relies on technical procedures related to PRP procurement and preservation because free radicals induce platelet activation and aging. This work aims to elucidate the oxidative mechanisms involved in activation of platelets obtained from PRP during storage. Materials and Methods: One hundred ten PRP batches were obtained from healthy donors and kept under stirring at a temperature of 20-24 °C. Protein extraction was performed from platelet homogenates and plasma at different times of storage from day 1 to 20. The activities of antioxidant markers such as catalase (CAT), superoxide dismutase, and ceruloplasmin, as well as fibrinolytic protein activity metalloproteases 2 and 3, plasmin, and urokinase plasminogen activator, were analyzed by zymography assays. Oxidized proteins were also determined. Results: Significant activity of antioxidant enzymes and fibrinolytic molecules was observed on day 5 of storage in PRP homogenates, which increased over time and was concomitantly correlated with oxidized protein levels. Reverse enzymatic activity patterns were observed in plasma, except for CAT, which remained unchanged. Conclusion: Storage conditions of platelets from PRP for up to 5 days induced in vitro platelet activation by oxidative damage and proteolysis. This finding confirms the need for proper management of these blood products to preserve their viability and functionality.

Indexed as

AntioxidantsPlatelet-Rich PlasmaBlood PlateletsHumansThrombolytic TherapyAntioxidantsMetalloproteasesOxidative damagePlatelet activationPlatelet-rich plasmaPlatelet storage

Identifiers

PMID36718633
PMCPMC9979738
OpenAlexW4318483446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.